Koyfin Home > Directory > Health Care > Aduro Biotech > Cost of Goods Sold

Aduro Biotech Cost of Goods Sold Chart (ADRO)

Aduro Biotech annual/quarterly Cost of Goods Sold from 2013 to 2020.
  • Aduro Biotech Cost of Goods Sold for the quarter ending June 06, 2020 was $11m a -39.63% decrease of -4m year over year
  • Aduro Biotech Cost of Goods Sold for the last 12 months ending June 06, 2020 was $59m a -14.70% decrease of -9m year over year
  • Aduro Biotech Annual Cost of Goods Sold for 2019 was $66m a -15.13% decrease of -10m from 2018
  • Aduro Biotech Annual Cost of Goods Sold for 2018 was $76m a -17.86% decrease of -14m from 2017
  • Aduro Biotech Annual Cost of Goods Sold for 2017 was $89m a 1.86% increase of 2m from 2016
Other Income Statement Metrics:
  • Aduro Biotech EBITDA for the quarter ending December 12, 2018 was $-23m a 9.58% decrease of -2m year over year
  • Aduro Biotech Net Income for the quarter ending December 12, 2018 was $-26m a 18.34% decrease of -5m year over year
  • Aduro Biotech Total Revenue for the quarter ending December 12, 2018 was $3m a -140.28% decrease of -4m year over year
View Chart On Koyfin

Quarterly ADRO Cost of Goods Sold Data

06/2020$11m
03/2020$16m
12/2019$15m
09/2019$16m
06/2019$17m
03/2019$17m
12/2018$18m
09/2018$19m
06/2018$19m
03/2018$20m

Annual ADRO Cost of Goods Sold Data

2019$66m
2018$76m
2017$89m
2016$88m
2015$59m
2014$24m
2013$11m
2012$7m